Clinical Trials, Phase IV as Topic [klinické zkoušky, fáze IV jako téma]

topical
51
Terms

evaluační studie, FDA fáze IV
klinické hodnocení fáze IV
klinické hodnocení léčiv, fáze IV
klinické hodnocení léčiv, FDA fáze IV
klinické zkoušky - fáze IV - jako téma

 

Clinical Trials, Phase 4 as Topic
Drug Evaluation, FDA Phase 4 as Topic
Drug Evaluation, FDA Phase IV as Topic
Evaluation Studies, FDA Phase 4 as Topic
Evaluation Studies, FDA Phase IV as Topic

Persistent link   https://www.medvik.cz/link/D017327
Definition

Works about planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.

Annotation
for general design, methodology, economics, etc. of phase IV clinical trials; a different heading CLINICAL TRIAL, PHASE IV is used for reports of a specific phase IV clinical trial
DUI
D017327 MeSH Browser
CUI
M0026314
Previous indexing
Clinical Trials (1980-1992)
History note
2008(1993)
Public note
2008; see CLINICAL TRIALS, PHASE IV 1993-2007; for DRUG EVALUATION, FDA PHASE IV see CLINICAL TRIALS 1981-1992; for EVALUATION STUDIES, FDA PHASE IV see CLINICAL TRIALS 1982-1992

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E05.318.372.250 Clinical Studies as Topic 3 293
E05.318.372.250.250 Clinical Trials as Topic 4 799
E05.318.372.250.250.100 Adaptive Clinical Trials as Topic 1
E05.318.372.250.250.200 Clinical Trials, Phase I as Topic 171
E05.318.372.250.250.210 Clinical Trials, Phase II as Topic 482
E05.318.372.250.250.220 Clinical Trials, Phase III as Topic 1 400
E05.318.372.250.250.230 Clinical Trials, Phase IV as Topic 51
E05.318.372.250.250.365 Controlled Clinical Trials as Topic 165
E05.318.372.250.250.524 Human Challenge Trials as Topic
E05.318.372.250.250.682 Single-Case Studies as Topic 2
E05.337.800.600 Pharmacovigilance 228

N Health Care
N05.715.360.330.250 Clinical Studies as Topic 3 293
N05.715.360.330.250.250 Clinical Trials as Topic 4 799
N05.715.360.330.250.250.100 Adaptive Clinical Trials as Topic 1
N05.715.360.330.250.250.200 Clinical Trials, Phase I as Topic 171
N05.715.360.330.250.250.210 Clinical Trials, Phase II as Topic 482
N05.715.360.330.250.250.220 Clinical Trials, Phase III as Topic 1 400
N05.715.360.330.250.250.230 Clinical Trials, Phase IV as Topic 51
N05.715.360.330.250.250.365 Controlled Clinical Trials as Topic 165
N05.715.360.330.250.250.524 Human Challenge Trials as Topic
N05.715.360.330.250.250.682 Single-Case Studies as Topic 2
N06.850 Public Health 4 041
N06.850.520 Epidemiologic Methods 1 030
N06.850.520.450.250 Clinical Studies as Topic 3 293
N06.850.520.450.250.250 Clinical Trials as Topic 4 799
N06.850.520.450.250.250.100 Adaptive Clinical Trials as Topic 1
N06.850.520.450.250.250.200 Clinical Trials, Phase I as Topic 171
N06.850.520.450.250.250.210 Clinical Trials, Phase II as Topic 482
N06.850.520.450.250.250.220 Clinical Trials, Phase III as Topic 1 400
N06.850.520.450.250.250.230 Clinical Trials, Phase IV as Topic 51
N06.850.520.450.250.250.365 Controlled Clinical Trials as Topic 165
N06.850.520.450.250.250.524 Human Challenge Trials as Topic
N06.850.520.450.250.250.682 Single-Case Studies as Topic 2